Suche starten De menü ClientConnect
Suche starten
Ergebnisse
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20170216
    Veröffentlichungsdatum: 30 Mai 2017

    Projektträger – zwischengeschaltetes Finanzinstitut

    CELLNOVO GROUP SA

    Ort

    Beschreibung

    Investment in Cellnovo's facilities in order to develop its innovative connected all-in-one diabetes management system focused primarily on type 1 diabetes patients

    Ziele

    The aim of the project is to scale up production of Cellnovo's novel micro-pump for type 1 diabetes patients and support related capital expenditure for products it plans to bring to the market in the future.

    Sektor(en)

    • Dienstleistungen - Erbringung von Freiberuflichen, Wissenschaftlichen und Technischen Dienstleistungen

    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 20 million

    Gesamtkosten (voraussichtlicher Betrag)

    EUR 41 million

    Umweltaspekte

    All project activities are expected to be carried out in existing facilities without changing the already authorised scope and would therefore not require an environmental impact assessment (EIA) under Directive 2014/52/EU amending the EIA Directive 2011/92/EU.

    Auftragsvergabe

    The promoter has been assessed by the EIB as being a private company not subject to EU rules on public procurement or concessions.

    Projektstatus

    Unterzeichnet - 7/07/2017

    Haftungsausschluss

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Tags

    Frankreich Dienstleistungen